Financials Daebongls.Co.,Ltd.

Equities

A078140

KR7078140001

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-07-01 pm EDT 5-day change 1st Jan Change
14,210 KRW +14.41% Intraday chart for Daebongls.Co.,Ltd. +32.56% +55.13%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 70,067 76,165 123,061 93,238 88,582 101,553
Enterprise Value (EV) 1 48,995 52,328 58,516 40,899 24,595 59,819
P/E ratio 11.3 x 13.3 x 21.1 x 13.6 x 10.1 x 24 x
Yield 0.79% 0.73% 0.45% 0.59% 0.63% 0.55%
Capitalization / Revenue 0.98 x 1.1 x 1.61 x 1.12 x 0.95 x 1.16 x
EV / Revenue 0.68 x 0.75 x 0.77 x 0.49 x 0.26 x 0.68 x
EV / EBITDA 5.07 x 5.4 x 5.46 x 3.24 x 2.18 x 8.31 x
EV / FCF 18.2 x -13.3 x 7.76 x -122 x -13.8 x -12.9 x
FCF Yield 5.5% -7.53% 12.9% -0.82% -7.25% -7.77%
Price to Book 0.94 x 0.94 x 1.18 x 0.84 x 0.75 x 0.83 x
Nbr of stocks (in thousands) 11,087 11,087 11,087 11,087 11,087 11,087
Reference price 2 6,320 6,870 11,100 8,410 7,990 9,160
Announcement Date 3/21/19 3/18/20 3/22/21 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 71,823 69,537 76,255 82,957 93,504 87,622
EBITDA 1 9,666 9,689 10,717 12,623 11,289 7,199
EBIT 1 7,923 7,352 8,122 9,685 8,174 3,801
Operating Margin 11.03% 10.57% 10.65% 11.68% 8.74% 4.34%
Earnings before Tax (EBT) 1 8,046 7,733 8,679 12,195 10,713 6,305
Net income 1 6,223 5,727 5,821 6,789 8,628 4,182
Net margin 8.66% 8.24% 7.63% 8.18% 9.23% 4.77%
EPS 2 561.3 516.5 526.0 619.0 788.0 382.0
Free Cash Flow 1 2,696 -3,940 7,538 -335.4 -1,784 -4,645
FCF margin 3.75% -5.67% 9.89% -0.4% -1.91% -5.3%
FCF Conversion (EBITDA) 27.89% - 70.34% - - -
FCF Conversion (Net income) 43.32% - 129.5% - - -
Dividend per Share 2 50.00 50.00 50.00 50.00 50.00 50.00
Announcement Date 3/21/19 3/18/20 3/22/21 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 21,072 23,837 64,545 52,339 63,987 41,734
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 2,696 -3,940 7,538 -335 -1,784 -4,645
ROE (net income / shareholders' equity) 9.02% 7.75% 6.93% 7.55% 8.25% 4.1%
ROA (Net income/ Total Assets) 5.92% 4.86% 4.03% 3.87% 2.92% 1.25%
Assets 1 105,173 117,806 144,433 175,531 295,003 335,459
Book Value Per Share 2 6,731 7,289 9,423 9,993 10,701 11,027
Cash Flow per Share 2 836.0 1,057 909.0 560.0 655.0 1,295
Capex 1 3,596 7,163 8,570 6,321 5,532 9,422
Capex / Sales 5.01% 10.3% 11.24% 7.62% 5.92% 10.75%
Announcement Date 3/21/19 3/18/20 3/22/21 3/21/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A078140 Stock
  4. Financials Daebongls.Co.,Ltd.